Ed Schoonveld
Routledge
Global drug pricing is one of the most hotly debated yet least understood aspects of the pharmaceutical industry. How should drug prices be set and what does it mean for patients? Why do governments increasingly get involved, and what is its impact on the global competitive environment? How can a life-saving industry have a poorer image than gun and tobacco industries, whose products are associated with death?
The Price of Global Health is a specialist textbook aimed at a wide range of audiences from healthcare industry professionals to policymakers, consumers, pharmaceutical company leaders and access and pricing professionals.
It explains how pharmaceutical prices are determined in a complex global payer environment and what factors influence the process, helping readers to gain a better understanding of this highly complex and emotionally charged field.
Ed Schoonveld is Managing Partner of the Value and Access Practice with ZS Associates. He previously led global pricing functions for Wyeth, Lilly and BMS and consulting practices in Cambridge Pharma/IMS.
AMBA members can save 20% on all books available in print on routledge.com, including The Price of Global Health. Simply add the discount code MBA20 to your basket when checking out.
